STLN congressional trades
Starling Oncology, Inc. - Common Stock (STLN) appears in 12 congressional disclosure rows from 1 member of Congress in 2025–2026 periodic reports: 0 purchases and 12 sales, with trade dates from Sep 18, 2026 to Sep 23, 2026. The median gap between trade date and filing date is 34 days, and every trade was reported within 45 days.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live STLN portfolio or a trading signal.
- 12
- 1
- 0 / 12
- $96K to $390K
- sum of reported ranges
- 2026-09-23
Verified STLN congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 12 sales. Reported owners: Spouse. Transaction dates run from 2026-09-18 to 2026-09-23.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $1,001 - $15,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $1,001 - $15,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $1,001 - $15,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $15,001 - $50,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $15,001 - $50,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $1,001 - $15,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $15,001 - $50,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $1,001 - $15,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $15,001 - $50,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $15,001 - $50,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $1,001 - $15,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 | |
| Richard Blumenthal | Starling Oncology, Inc. - Common Stock | Sale | Spouse | $15,001 - $50,000 | #e67780bf-56e4-46f0-a81e-574a701dd539 Filed 2026-10-26 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
STLN disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| Richard Blumenthal's STLN trades | 12 | 0 | 12 | 2026-09-23 |
How long disclosure took
Days from trade date to filing date for 12 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 0
- 16–30 days
- 0
- 31–45 days
- 12
- Over 45 days
- 0
- Median / longest
- 34d / 38d
Source documents
1 House Clerk and Senate eFD periodic transaction report, newest first. Each link opens the official filing.
- #e67780bf-56e4-46f0-a81e-574a701dd539Filed 2026-10-26 · 12 rows
What STLN filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- Issue 09: Is Nvidia Stock a Buy at 10x Earnings Without Huang?
At $155.46, Nvidia trades at 9.8 times next year's expected earnings, about half the S&P 500's multiple. What the price assumes, and our three calls.
- Issue 08: Who Pays for a 5% Treasury? Stocks Hurt by Rising Rates
Homebuilders fall about five times as much as the S&P 500 when Treasury yields rise, and banks don't gain. Our 2026 rate screen, valuations and three calls.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchSTLN congressional trades: FAQ
Who in Congress traded STLN?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 12 verified STLN rows from 1 member: Richard Blumenthal. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current STLN holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are STLN amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $1,001 - $15,000; $15,001 - $50,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is STLN congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (179 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded STLN.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-11-19. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported STLN and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included